Abstract
In this issue of Blood, Shah et al describe the onset of severe acute graft-versus-host disease (GVHD) in 5 of 9 patients who received infusions of ex vivo expanded donor natural killer (NK) cells after HLA-matched hematopoietic stem cell transplantation (HSCT).1
Original language | English (US) |
---|---|
Pages (from-to) | 744-745 |
Number of pages | 2 |
Journal | Blood |
Volume | 125 |
Issue number | 5 |
DOIs |
|
State | Published - Jan 29 2015 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology